http://bmctoday.net/evtoday/ The latest news stories from Endovascular Today. en-us Wed, 19 Jun 2013 12:12:22 GMT Wed, 19 Jun 2013 12:12:22 GMT BMCToday http://bmctoday.net/evtoday/2013/05/article.asp?f=study-supports-ultrasound-guided-access-for-cli-treatment June 1, 2013—A single-center study of the utility and feasibility of ultrasound-guided access in patients with critical limb ischemia (CLI) was published by J.A. Mustapha, MD, et al in a href="http://onlinelibrary.wiley.com/doi/10.1002/ccd.24757/abstract" class="" classname="" target="" name=""Catheterization and Cardiova... Thu, 2 May 2013 04:00:00 GMT http://bmctoday.net/evtoday/2013/05/article.asp?f=study-supports-ultrasound-guided-access-for-cli-treatment http://bmctoday.net/evtoday/2013/05/article.asp?f=role-of-radiologists-in-central-venous-procedures-has-greatly-expanded June 18, 2013—The Harvey L. Neiman Health Policy Institute (HPI) announced that an institute-sponsored study confirms a major shift in practice at American hospitals regarding central venous procedures. The study found that treatments that were traditionally the domain of surgeons and anesthesiologists are now being perfo... Thu, 2 May 2013 04:00:00 GMT http://bmctoday.net/evtoday/2013/05/article.asp?f=role-of-radiologists-in-central-venous-procedures-has-greatly-expanded http://bmctoday.net/evtoday/2013/05/article.asp?f=cardiatis-multilayer-flow-modulator-stents-show-promise-for-taaa-treatment-in-early-stage-registry-results June 6, 2013—A multilayer flow modulator stent (Cardiatis, Isnes, Belgium) shows promise in the treatment of thoracoabdominal aortic aneurysms (TAAA), according to a study by Sherif Sultan, MD, and Niamh Hynes, MD, published in a href="http://jevt.org/doi/full/10.1583/12-4077MR-R.1" class="" classname="" target="" name=""... Thu, 2 May 2013 04:00:00 GMT http://bmctoday.net/evtoday/2013/05/article.asp?f=cardiatis-multilayer-flow-modulator-stents-show-promise-for-taaa-treatment-in-early-stage-registry-results http://bmctoday.net/evtoday/2013/05/article.asp?f=european-societies-issue-2013-guidelines-for-the-management-of-arterial-hypertension June 14, 2013—The European Society of Hypertension (ESH) and European Society of Cardiology (ESC) issued the 2013 ESH/ESC Guidelines for the management of arterial hypertension, including renal denervation to treat uncontrolled hypertension. The guidelines were introduced at the ESH scientific meeting in Milan, Italy, and... Thu, 2 May 2013 04:00:00 GMT http://bmctoday.net/evtoday/2013/05/article.asp?f=european-societies-issue-2013-guidelines-for-the-management-of-arterial-hypertension http://bmctoday.net/evtoday/2013/05/article.asp?f=teleflex-receives-fda-clearance-for-arrow-nextstep-retrograde-femoral-length-dialysis-catheters June 10, 2013—Teleflex Incorporated (Limerick, PA) has received FDA 510(k) clearance to market its Arrow NextStep retrograde femoral-length dialysis catheters, part of the NextStep Hemodialysis Catheter portfolio. The Arrow NextStep retrograde hemodialysis catheter is designed to take advantage of the blood flow dynami... Thu, 2 May 2013 04:00:00 GMT http://bmctoday.net/evtoday/2013/05/article.asp?f=teleflex-receives-fda-clearance-for-arrow-nextstep-retrograde-femoral-length-dialysis-catheters http://bmctoday.net/evtoday/2013/05/article.asp?f=st-jude-medical-initiates-first-us-clinical-study-of-the-enlightn-renal-denervation-system June 4, 2013—St. Jude Medical, Inc. (St. Paul, MN) announced US Food and Drug Administration (FDA) approval to begin the EnligHTN IV renal denervation study, the first United States trial using the EnligHTN multielectrode renal denervation system to treat patients with drug-resistant high blood pressure. “Suboptimal ... Thu, 2 May 2013 04:00:00 GMT http://bmctoday.net/evtoday/2013/05/article.asp?f=st-jude-medical-initiates-first-us-clinical-study-of-the-enlightn-renal-denervation-system http://bmctoday.net/evtoday/2013/05/article.asp?f=medtronics-pacific-plus-pta-catheter-cleared-in-us-and-europe June 4, 2013—Medtronic, Inc. (Minneapolis, MN) has received 510(k) clearance from the US Food and Drug Administration as well as the CE Mark for its Pacific Plus percutaneous transluminal angioplasty (PTA) catheter. Pacific Plus is indicated for use in a variety of peripheral arterial locations, including narrowing of the... Thu, 2 May 2013 04:00:00 GMT http://bmctoday.net/evtoday/2013/05/article.asp?f=medtronics-pacific-plus-pta-catheter-cleared-in-us-and-europe http://bmctoday.net/evtoday/2013/05/article.asp?f=biosensors-enters-into-licensing-agreement-with-eurocor-for-drug-eluting-balloon-range May 31, 2013—Biosensors International Group, Ltd. (Singapore) has entered into a licensing agreement with Eurocor GmbH, a group company of Opto Circuits (India) Ltd. (Karnakata, India), for their drug-eluting balloon (DEB) technology and related intellectual property rights in relation to the treatment of both coronary an... Thu, 2 May 2013 04:00:00 GMT http://bmctoday.net/evtoday/2013/05/article.asp?f=biosensors-enters-into-licensing-agreement-with-eurocor-for-drug-eluting-balloon-range http://bmctoday.net/evtoday/2013/05/article.asp?f=american-academy-of-neurology-guideline-covers-managing-antithrombotics-before-procedures May 27, 2013—The American Academy of Neurology’s new "Evidence-based Guideline: Periprocedural Management of Antithrombotic Medications in Patients with Ischemic Cerebrovascular Disease," published a href="http://neurology.org/content/80/22/2065" class="" classname="" target="" name=""online/a and in Neurology (2013;80:... Thu, 2 May 2013 04:00:00 GMT http://bmctoday.net/evtoday/2013/05/article.asp?f=american-academy-of-neurology-guideline-covers-managing-antithrombotics-before-procedures http://bmctoday.net/evtoday/2013/05/article.asp?f=medtronic-reaches-milestone-in-clinical-program-for-inpact-admiral-drug-eluting-balloon June 3, 2013—Medtronic, Inc. (Minneapolis, MN) announced that enough patients have been enrolled in its clinical studies of the In.Pact Admiral drug-eluting balloon to support the company’s United States regulatory approval submission of the device, which is designed to treat atherosclerotic lesions in the superficial f... Thu, 2 May 2013 04:00:00 GMT http://bmctoday.net/evtoday/2013/05/article.asp?f=medtronic-reaches-milestone-in-clinical-program-for-inpact-admiral-drug-eluting-balloon http://bmctoday.net/evtoday/2013/05/article.asp?f=cardiovascular-systems-enrolls-first-patient-in-liberty-360-postmarket-study May 30, 2013—Cardiovascular Systems, Inc. (CSI; St. Paul, MN), announced that the first patient has been enrolled in its postmarket study, LIBERTY 360°. The study is evaluating the acute and long-term clinical and economic outcomes of CSI’s orbital atherectomy system in treating peripheral arterial disease (PAD). Addit... Thu, 2 May 2013 04:00:00 GMT http://bmctoday.net/evtoday/2013/05/article.asp?f=cardiovascular-systems-enrolls-first-patient-in-liberty-360-postmarket-study http://bmctoday.net/evtoday/2013/05/article.asp?f=three-year-clinical-data-presented-for-endurant-aaa-stent-graft May 31, 2013—New data on the Endurant abdominal aortic aneurysm (AAA) stent graft system (Medtronic, Inc., Minneapolis, MN) were presented at the Society for Vascular Surgery’s Vascular Annual Meeting being held in San Francisco, California. The new data demonstrate durable clinical performance through 3 years of patien... Thu, 2 May 2013 04:00:00 GMT http://bmctoday.net/evtoday/2013/05/article.asp?f=three-year-clinical-data-presented-for-endurant-aaa-stent-graft